Long-term biochemical control and cause-specific survival in men with Gleason grade Group 4 and 5 prostate cancer treated with brachytherapy and external beam irradiation.
Brachytherapy(2020)
摘要
Survival rates for high-grade prostate cancer are favorable when diagnosed in men with lower PSA and treated with doses of BED > 200 Gy. Higher BED is achieved with a combination of I-125 (110 Gy) or Pd-103 (100 Gy) and 45 Gy EBRT.
更多查看译文
关键词
Prostate cancer,Brachytherapy,High grade,Survival
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络